Replimune Group, Inc. (REPL) vs Y-mAbs Therapeutics, Inc. (YMAB)
Detailed comparison between Replimune Group, Inc., Y-mAbs Therapeutics, Inc..Total Return (%)
Replimune Group, Inc. (REPL)Y-mAbs Therapeutics, Inc. (YMAB)
Which stock do you think will perform better?
Replimune Group, Inc.
REPL
Y-mAbs Therapeutics, Inc.
YMAB
| Metric | Replimune Group, Inc. (REPL) | Y-mAbs Therapeutics, Inc. (YMAB) |
|---|---|---|
| Current Price | $9.19 | $4.23 |
| Change | 0.99 (12.07%) | 0.06 (1.44%) |
| Market Cap | $0.71B | $0.19B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -3.42 | -7.29 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $17.00 | $16.11 |
| 52-Week Low | $4.92 | $3.55 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-3.07 | $-0.64 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| REPL | -6.03% | -32.53% | 80.20% | -53.49% | -39.38% | -39.38% |
| YMAB | -0.47% | -31.66% | -64.78% | -90.15% | -82.38% | -82.38% |